Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal Carcinomatosis

Rahul Rajeev, MBBS; Kiran K. Turaga, MD


Cancer Control. 2016;23(1):36-46. 

In This Article

Future Directions

Improving methods for appropriate patient selection and advancing surgical techniques are disruptive changes that will alter the treatment landscape for peritoneal carcinomatosis. Use of telemedicine, robotic assistance, and immersive simulations for training and interventions are likely to optimize the field of surgery. Dynamic techniques for accurate, intraoperative, pathological diagnoses can prevent unnecessary interventions. Robotic-assisted cytoreductive surgery for peritoneal disease has already been successfully used in metastatic ovarian cancers.[95] In addition, with the advent of telesurgery, HIPEC can be introduced to areas that lack trained surgical oncologists.